to pharmaceutical market forecasting and oncology forecasting. He has also created custom market models, epidemiology models, and forecasting platforms for dozens of pharmaceutical company clients. Kevin holds a B.S.B.A. (Finance), magna cum laude, from the University of Missouri – St. Louis. ...